Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.
about
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cellsRescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancerJagged-Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype.Challenges and future perspectives of T cell immunotherapy in cancerMultivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk.Vascular normalization as an emerging strategy to enhance cancer immunotherapy.Notching tumor: Signaling through Notch receptors improves antitumor T cell immunity.Effects of notch signaling on regulation of myeloid cell differentiation in cancer.The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorderTumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progressionBortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.The challenge of targeting notch in hematologic malignancies.Notch signaling in lung diseases: focus on Notch1 and Notch3.EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.Cancer therapy by resuscitating Notch immune surveillance.Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance.Improving immune-vascular crosstalk for cancer immunotherapy.[Up-regulation of DLL1 may promote the chemotherapeutic sensitivity in small cell lung cancer].Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent mannerCancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
P2860
Q28256749-11AD7FB4-4F26-4CF3-A3F9-E6181926BC93Q34017104-A0D446FD-50C7-4264-BFFE-AAA886E7B87BQ35062669-9DE3C3BF-7AD4-4560-B931-74349930FC6DQ35843507-9B368AFA-42B7-4DA0-B4C5-0E8779EB0CAEQ36296504-F3F5CA84-C7AA-4105-B7DA-3E3AE7B68CAFQ36544872-2E8B7B8F-4704-40C9-9424-A4FCB4C91141Q36847357-9B21DEE2-7A09-4747-9898-EB62D33A7C8FQ37012585-61F2BE45-EA9B-413C-B49F-16677B74D73AQ37456808-6430D081-4C90-4277-AE76-2788840345B8Q37665224-E51F11C2-389A-48CA-87DF-53D8698C73E3Q37700357-33D6F689-7F95-4F9E-8D73-92B9F6F04ACEQ37702765-04869DD0-7CA4-4073-9675-6528C3F331C3Q38222770-A9DCD794-B8D6-4098-A47F-1F4D441430E5Q38845270-702E5471-568C-499E-B311-7C6AF2674B5EQ38965827-B356E5CF-C228-4710-A77C-E4B207322E27Q45967534-EBC061BD-2F55-4A4C-9642-09DA4DA9600AQ47807019-6693D53A-C071-44E9-9634-B2A49DCF88CCQ50051034-70C3D580-1744-41E9-B1D0-A795BC86E9A2Q50478933-F6488E94-5F86-4ED4-B8FA-F719A07C6AA7Q58104263-708F35C3-8E37-45FB-9867-899789424187Q58781616-66752DE3-4E0B-478B-A793-74180BC4289C
P2860
Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Resuscitating cancer immunosur ...... ion and inhibits tumor growth.
@ast
Resuscitating cancer immunosur ...... ion and inhibits tumor growth.
@en
type
label
Resuscitating cancer immunosur ...... ion and inhibits tumor growth.
@ast
Resuscitating cancer immunosur ...... ion and inhibits tumor growth.
@en
prefLabel
Resuscitating cancer immunosur ...... ion and inhibits tumor growth.
@ast
Resuscitating cancer immunosur ...... ion and inhibits tumor growth.
@en
P2093
P2860
P1433
P1476
Resuscitating cancer immunosur ...... ion and inhibits tumor growth.
@en
P2093
Anshu Malhotra
David P Carbone
Luping Lin
Mikhail M Dikov
Yuhui Huang
P2860
P304
P356
10.1158/0008-5472.CAN-10-4366
P407
P50
P577
2011-08-08T00:00:00Z